Form 8-K · Item 4.01 · Auditor change
NRX Pharmaceuticals, Inc.: auditor change, Salberg & Company P.A. to Weinberg & Company P.A.
NRX Pharmaceuticals, Inc. reported in a Form 8-K filed November 26, 2025, that in November 2025, Salberg & Company P.A. was dismissed as its certifying accountant, and Weinberg & Company P.A. was engaged. The filing reports no disagreements with the former accountant.
In the filing's words
On November 20, 2025, the audit committee of the board of directors (the “Audit Committee”) of NRx Pharmaceuticals, Inc. (the “Corporation”) approved the engagement of Weinberg & Company P.A. (“Weinberg”) as the Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
on or around November 24, 2025 the Audit Committee of the Corporation dismissed Salberg & Company P.A. (“Salberg”) as the Corporation’s independent registered public accounting firm.
there were no “disagreements” (within the meaning set forth in Item 304(a)(1)(iv) of Regulation S-K) between the Corporation and Salberg on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | NRX Pharmaceuticals, Inc. |
|---|---|
| Ticker | NRXP |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | November 26, 2025 |
| What the filing states | dismissed, engaged |
| Former accountant | Salberg & Company P.A. |
| New accountant | Weinberg & Company P.A. |
| Date of the change | November 2025 |
| Disagreements | none reported |
| Auditor's letter | Exhibit 16 on sec.gov |
| Accession number | 0001437749-25-036452 |
| SEC CIK | 0001719406 |
NRX Pharmaceuticals, Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed November 26, 2025. The filing's own words are quoted above.
Sources
More: all auditor changes · Something wrong? Send a correction with the primary source.